At week 2 , infliximab-treated patients had greater mean reductions in erythrocyte sedimentation rate ( p = 0009 ) and a two-fold greater decrease in Z score of the left anterior descending artery ( p = 0045 ) than did those in the placebo group , but this difference was not significant at week 5 .